(Q41721101)

8 October 2017

Likelihood of spontaneous conversion of atrial fibrillation to sinus rhythm (English)

1 reference

8 October 2017

0 references

5

Manning WJ

1 reference

8 October 2017

Danias PG

1

1 reference

8 October 2017

Caulfield TA

series ordinal

2

1 reference

8 October 2017

Weigner MJ

series ordinal

3

1 reference

8 October 2017

Silverman DI

series ordinal

4

1 reference

8 October 2017

language of work or name

English

0 references

publication date

1 March 1998

1 reference

Journal of the American College of Cardiology

8 October 2017

1 reference

8 October 2017

31

1 reference

8 October 2017

3

1 reference

8 October 2017

588-592

1 reference

ELECTROCARDIOGRAPHIC FINDINGS AMONG THE ADULT POPULATION OF A TOTAL NATURAL COMMUNITY, TECUMSEH, MICHIGAN

8 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900534-2

7 January 2021

Epidemiologic features of chronic atrial fibrillation: the Framingham study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900534-2

7 January 2021

Management of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900534-2

7 January 2021

Management of patients with atrial fibrillation. A Statement for Healthcare Professionals. From the Subcommittee on Electrocardiography and Electrophysiology, American Heart Association

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900534-2

7 January 2021

Antithrombotic therapy in atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900534-2

7 January 2021

Risk for clinical thromboembolism associated with conversion to sinus rhythm in patients with atrial fibrillation lasting less than 48 hours

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900534-2

7 January 2021

Digoxin for converting recent-onset atrial fibrillation to sinus rhythm. A randomized, double-blinded trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900534-2

7 January 2021

Intravenous amiodarone in treatment of recent-onset atrial fibrillation: results of a randomized, controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900534-2

7 January 2021

Intravenous amiodarone versus verapamil for acute conversion of paroxysmal atrial fibrillation to sinus rhythm

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900534-2

7 January 2021

Clinical course of recent-onset atrial fibrillation treated with oral propafenone

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900534-2

7 January 2021

Intravenous digoxin in acute atrial fibrillation. Results of a randomized, placebo-controlled multicentre trial in 239 patients. The Digitalis in Acute Atrial Fibrillation (DAAF) Trial Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900534-2

7 January 2021

Oral propafenone to convert recent-onset atrial fibrillation in patients with and without underlying heart disease. A randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900534-2

7 January 2021

Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900534-2

7 January 2021

Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900534-2

7 January 2021

QUINIDINE SYNCOPE. PAROXYSMAL VENTRICULAR FIBRILLATION OCCURRING DURING TREATMENT OF CHRONIC ATRIAL ARRHYTHMIAS.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900534-2

7 January 2021

"Cardioversion" of atrial fibrillation. A report on the treatment of 65 episodes in 50 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900534-2

7 January 2021

Risk of initiating antiarrhythmic drug therapy for atrial fibrillation in patients admitted to a university hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900534-2

7 January 2021

Comparison of the efficacy and safety of esmolol, a short-acting beta blocker, with placebo in the treatment of supraventricular tachyarrhythmias. The Esmolol vs Placebo Multicenter Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900534-2

7 January 2021

Effect of intravenous and oral calcium antagonists (diltiazem and verapamil) on sustenance of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900534-2

7 January 2021

Intravenous flecainide versus verapamil for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900534-2

7 January 2021

Esmolol versus verapamil in the acute treatment of atrial fibrillation or atrial flutter

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900534-2

7 January 2021

Sotalol versus quinidine for the maintenance of sinus rhythm after direct current conversion of atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900534-2

7 January 2021

Comparisons of oral propafenone and sotalol as an initial treatment in patients with symptomatic paroxysmal atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900534-2

7 January 2021

Transesophageal echocardiographically facilitated early cardioversion from atrial fibrillation using short-term anticoagulation: final results of a prospective 4.5-year study.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900534-2

7 January 2021

The efficacy of anticoagulant therapy in preventing embolism related to D.C. electrical conversion of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900534-2

7 January 2021

Cardioversion guided by transesophageal echocardiography: the ACUTE Pilot Study. A randomized, controlled trial. Assessment of Cardioversion Using Transesophageal Echocardiography

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900534-2

7 January 2021

Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900534-2

7 January 2021

Echocardiographic and clinical predictors for outcome of elective cardioversion of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900534-2

7 January 2021

10.1016/S0735-1097(97)00534-2

Identifiers

DOI

1 reference

8 October 2017

1 reference